唾液酸转移酶在口腔鳞癌中的研究进展
摘要
癌(Oral squamous cell carcinoma,OSCC)的侵袭、转移、免疫逃逸及不良预后密切相关。本文围绕STs在OSCC中
的表达特征、生物学作用及临床转化研究进展进行综述,并探讨其在早期筛查、风险分层和靶向干预中的潜在价值,
以期为OSCC相关机制研究及精准诊疗提供参考。
关键词
全文:
PDF参考
[1]Johnson DE, Burtness B, Leemans CR, et al. Head
and neck squamous cell carcinoma[J]. Nat Rev Dis Primers,
2020, 6(1):92.
[2]Ferris RL, Blumenschein G Jr, Fayette J, et al.
Nivolumab for recurrent squamous-cell carcinoma of the
head and neck[J]. N Engl J Med, 2016, 375(19):1856-1867.
[3]肖呐呐,王星,白嘉璐,等.唾液酸转移酶在恶
性肿瘤发生发展中的作用[J].中华实验外科杂志,2025,
42(12):2645-2652.
[4]Mehta KA, Patel KA, Pandya SJ, et al. Aberrant
sialylation plays a significant role in oral squamous cell carcinoma
progression[J]. J Oral Pathol Med, 2020, 49(3):253-259.
[5]Vajaria BN, Patel KR, Begum R, et al. Salivary
glyco-sialylation changes monitors oral carcinogenesis[J].
Glycoconj J, 2014, 31(9):649-659.
[6]Shah MH, Telang SD, Shah PM, et al. Tissue and
serum α2-3- and α2-6-linkage specific sialylation changes
in oral carcinogenesis[J]. Glycoconj J, 2008, 25(3):279-290.
[7]Silva BS, Yamamoto-Silva FP, Pontes HA, et al.
E-cadherin downregulation and Twist overexpression since
early stages of oral carcinogenesis[J]. J Oral Pathol Med, 2014,
43(2):125-131.
[8]Lin WL, Lin YS, Shi GY, et al. Lewis y promotes
migration of oral cancer cells by glycosylation of epidermal
growth factor receptor[J]. PLoS One, 2015, 10(3):e0120162.
[9]Ankenbauer KE, Rao TC, Mattheyses AL, et al.
Sialylation of EGFR by ST6GAL1 induces receptor activation
and modulates trafficking dynamics[J]. J Biol Chem, 2023,
299(10):105217.
[10]许青,段嘉蓉,郑天清.靶向唾液酸-Siglec在
肿瘤免疫治疗中的研究进展[J].中国肿瘤临床,2025,52
(02):81-85.
[11]Zou KL, Lan Z, Cui H, et al. CD24 blockade
promotes anti-tumor immunity in oral squamous cell
carcinoma[J]. Oral Dis, 2024, 30(1):163-171.
[12]周建军,王国栋.口腔鳞状细胞癌铂类药物耐药
分子机制研究进展[J].中国肿瘤生物治疗杂志,2019,26
(11):1288-1292.
Refbacks
- 当前没有refback。
